Researches showed that inflammatory mediators, such as interleukin 6 (IL-6), Toll-like receptor (TLR), signal transducer and activator of transcription 3 (STAT3), and nuclear factor-κB (NF-κB), are critical in the transformation from inflammation to tumor [8, 9]. This evidence concerns the gene IL6 and neoplasm.